What do case-control studies tell us about risk factors for antibiotic resistance? Christie Y. Jeon EPI502 Jan 22 nd, 2008.

Slides:



Advertisements
Similar presentations
Antimicrobial Prescribing in the Management of COPD
Advertisements

Making evidence more accessible using pictures
The Bahrain Branch of the UK Cochrane Centre In Collaboration with Reyada Training & Management Consultancy, Dubai-UAE Cochrane Collaboration and Systematic.
Introduction to Risk Factors & Measures of Effect Meg McCarron, CDC.
Evaluating Whether Interventions on the Use of Antibiotics Work to Decrease Resistance Chris Ford Regina Joice 1/18/08.
Modelling Two Host Strains with an Indirectly Transmitted Pathogen Angela Giafis 20 th April 2005.
What intervention on the use or dosing of antibiotics work to decrease resistance? Jan. 18, 2007 Sung-Ching Pan.
Relative and Attributable Risks. Absolute Risk Involves people who contract disease due to an exposure Doesn’t consider those who are sick but haven’t.
Infection Control Friday 1/11/08. Spread of resistance Antibiotic pressure Human to human transmission.
Chance Is the association causal? RR = 7 Detectives in the Classroom – Investigation 3-3: Chance.
What ecological studies can & can’t tell us Justin O’Hagan 2 nd year Epi Doctoral Student.
What can we learn from individual- level studies of antibiotic resistance? Molly Franke EPI 502 January 17, 2008.
Infectious Disease Epidemiology Sharyn Orton, Ph.D. American Red Cross, Rockville, MD Suggested reading: Modern Infectious Disease Epidemiology (1994)
HSTAT1101: 27. oktober 2004 Odd Aalen
Epidemiology Tools and Methods Session 2, Part 1.
Concepts of Interaction Matthew Fox Advanced Epi.
Epidemiology.
AETIOLOGY Case control studies (also RCT, cohort and ecological studies)
Designs to determine the impact of Ab resistance How do we correctly measure the outcomes of antibiotic resistance?
CHP400: Community Health Program- lI Research Methodology STUDY DESIGNS Observational / Analytical Studies Case Control Studies Present: Disease Past:
Retrospective Cohort Study. Review- Retrospective Cohort Study Retrospective cohort study: Investigator has access to exposure data on a group of people.
Study Designs Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /4/20151.
ECON ECON Health Economic Policy Lab Kem P. Krueger, Pharm.D., Ph.D. Anne Alexander, M.S., Ph.D. University of Wyoming.
Types of study designs Arash Najimi
 Is there a comparison? ◦ Are the groups really comparable?  Are the differences being reported real? ◦ Are they worth reporting? ◦ How much confidence.
Evaluation of the resistance of bacterial pathogens of synopulmonary infections in children L.Chernyshova F.Lapiy National Medical Academy of Postgraduate.
Conceptual Issues in Risk Prediction Colin B. Begg Memorial Sloan-Kettering Cancer Center.
Article Review Cara Carty 09-Mar-06. “Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of.
Nilofar Rahman, MD RISK OF RECURRENCE OF CLOSTRIDIUM DIFFICILE INFECTION WITH PPI USE.
Mother and Child Health: Research Methods G.J.Ebrahim Editor Journal of Tropical Pediatrics, Oxford University Press.
Alastair Hay, Consultant Senior Lecturer in Primary Health Care The TARGET Programme: strengths, weaknesses, opportunities and lessons learned (so far).
Is for Epi Epidemiology basics for non-epidemiologists.
Study Designs for Clinical and Epidemiological Research Carla J. Alvarado, MS, CIC University of Wisconsin-Madison (608)
Epidemiology: Basic concepts and principles ENV
Drug Safety and Risk Management Advisory Committee May 18-19, Overview of Drug Safety Challenges Gerald J. Dal Pan, MD, MHS Director Division of.
Wipanee Phupakdi, MD September 15, Overview  Define EBM  Learn steps in EBM process  Identify parts of a well-built clinical question  Discuss.
Lecture 9: Analysis of intervention studies Randomized trial - categorical outcome Measures of risk: –incidence rate of an adverse event (death, etc) It.
Basic concept of clinical study
Case-Crossover Studies.
Overview of Study Designs. Study Designs Experimental Randomized Controlled Trial Group Randomized Trial Observational Descriptive Analytical Cross-sectional.
Making epidemiological evidence more accessible using pictures Rod Jackson Updated November 09.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Procalcitonin Use to Predict Bacterial Infection in Febrile Infants Milcent K, Faesch.
Definitions Learning Objectives At the end of this lecture you (will) be able to: Understand definitions used in infectious disease epidemiology.
Case-Control Studies Abdualziz BinSaeed. Case-Control Studies Type of analytic study Unit of observation and analysis: Individual (not group)
Design and Analysis of Clinical Study 7. Analysis of Case-control Study Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
CROSS SECTIONAL STUDIES
Design of Clinical Research Studies ASAP Session by: Robert McCarter, ScD Dir. Biostatistics and Informatics, CNMC
CASE CONTROL STUDY. Learning Objectives Identify the principles of case control design State the advantages and limitations of case control study Calculate.
Tigecycline use in serious nosocomial infections: a drug use evaluation Matteo Bassetti*, Laura Nicolini, Ernestina Repetto, Elda Righi, Valerio Del Bono,
Purpose of Epi Studies Discover factors associated with diseases, physical conditions and behaviors Identify the causal factors Show the efficacy of intervening.
Clinical Infectious Diseases 2012;55(6):764–70 Jan Vydra,1 Ryan M. Shanley,2 Ige George,1 Celalettin Ustun,1 Angela R. Smith,4 Daniel J. Weisdorf,1 and.
Case Control study. An investigation that compares a group of people with a disease to a group of people without the disease. Used to identify and assess.
1 Infectious Diseases in the Nursing Home Setting: Challenges and Opportunities for Clinical Investigation 감염내과 R2 김대호 / Prof. 이미숙 Manisha Juthani-Mehta.
Comorbidity and Multimorbidity: Measurement and Interventions Holly M. Holmes, MD, MS Dept of General Internal Medicine.
Relative and Attributable Risks
EPID 503 – Class 12 Cohort Study Design.
Instructional Objectives:
3- Experimental Studies (Intervention Studies):
Vaccine Efficacy, Effectiveness and Impact
Class session 13 Case-control studies
Dual Goals for the Management of Stable Ischemic Heart Disease (SIHD)
Treatment of Complicated Intra-abdominal Infections
Interpreting Basic Statistics
E. Tacconelli  Clinical Microbiology and Infection 
Measures of Disease Occurrence
Dr Luis E Cuevas – LSTM Julia Critchley
Ob/Gyn Journal Club Notes
Effect Modifiers.
Presentation transcript:

What do case-control studies tell us about risk factors for antibiotic resistance? Christie Y. Jeon EPI502 Jan 22 nd, 2008

Outline Motivation Randomized Controlled Trial Understanding the outcomes OR S, OR C Variation of effect Confounding Multiplicative vs. Absolute

Motivation To identify the risk factors for infection with resistant pathogen Antibiotic use for a given infection A  A R, B  A R Who, where, what ? Why? Interventions Restrictions

Randomized Controlled Trial PR S = P[R] TX > 1 P[R] NoTx PR C = P[R I C] TX > 1 P[R I C] NoTx PR S < PR C

Case-control studies AB CaseColonized with resistant ControlsColonized with susceptible Colonized with susceptible OR not colonized Measure of Association OR Conditional OR Simple Example Interpretation of OR

Example – Harris et al. CID 2002 AB CaseCulture positive for imipenem-resistant P. aeruginosa ControlsCulture positive for imipenem-susceptible P. aeruginosa Randomly selected control patients from same medical services Interpretation of OR The increase in an individual’s risk of carrying imp R P. aeruginosa due to AB given an infection with susceptible P. aeruginosa(?) The increase in an individual’s risk of carrying imp R P. aeruginosa due to the particular AB Prediction : Given that an individual has recently been treated with a particular AB, the increased likelihood that the pathogen is imp R compared to not having been treated

Example – Harris et al. CID 2002 AB CaseCulture positive for imipenem-resistant P. aeruginosa ControlsCulture positive for imipenem-susceptible P. aeruginosa Randomly selected control patients from same medical services Interpretation of OR The increase in an individual’s risk of carrying imp R P. aeruginosa due to AB given an infection with susceptible P. aeruginosa(?) The increase in an individual’s risk of carrying imp R P. aeruginosa due to the particular AB Community effect : indirect effect of AB on the population as a whole by reducing the overall exposure to susceptible P. aeruginosa

Appropriate case-control design Q : “What are the risk factors for emergence of AB-resistance in pathogen X among patients previously infected with AB-susceptible pathogen X” A : Cases : individuals with resistant organism who previously had the susceptible form of the organism Controls : individuals with the susceptible pathogen and no subsequent resistant organism

Example – Harris et al. CID 2002

B  A R PR c B < PR c A PR c B = P[R I C] TX > 1 P[R I C] NoTx

Tx clears some R-pathogen PR S = P[R] TX < 1 P[R] NoTx PR C = P[R I C] TX >1 P[R I C] NoTx PR S < PR C

Outbreak PR S = P[R] TX > 1 P[R] NoTx PR C = P[R I C] TX >> 1 P[R I C] NoTx PR S < PR C

Confounding Time at risk of resistant pathogen Duration at risk of resistant pathogen Comorbid illness Location of recruitment

Multiplicative vs. Absolute Odds, Rate, Risk Ratio = multiplicative measure Prediction Causal association Rate Difference = absolute measure Burden of disease Population effect

Schwaber et al AB C D E

Recovering rates from case- control studies Rate TX = # cases TX controls TX x 3 Rate NoTx = # cases No Tx controls No Tx x 3

Summary Strength and meaning of the association of antibiotic use and resistance varies by Definition of the controls Effect on the susceptible strains The nature of the antibiotic Background incidence of resistance strains Absolute measures are better measure of burden of resistance in the population